27 research outputs found
In vitro antioxidant and ex vivo protective activities of green and roasted coffee.
The antioxidant properties of green and roasted coffee, in relation to species (Coffea arabica and Coffea robusta) and degree of roasting (light, medium, dark), were investigated. These properties were evaluated by determining the reducing substances (RS) of coffee and its antioxidant activity (AA) in vitro (model system beta-carotene-linoleic acid) and ex vivo as protective activity (PA) against rat liver cell microsome lipid peroxidation measured as TBA-reacting substances. RS of C. robustasamples were found to be significantly higher when compared to those of C. arabica samples (p < 0.001). AA for green coffee samples were slightly higher than for the corresponding roasted samples while PA was significantly lower in green coffee compared to that of all roasted samples (p < 0.001). Extraction with three different organic solvents (ethyl acetate, ethyl ether, and dichloromethane) showed that the most protective compounds are extracted from acidified dark roasted coffee solutions with ethyl acetate. The analysis of acidic extract by gel filtration chromatography (GFC) gave five fractions. Higher molecular mass fractions were found to possess antioxidant activity while the lower molecular mass fractions showed protective activity. The small amounts of these acidic, low molecular mass protective fractions isolated indicate that they contain very strong protective agents
In vitro antioxidant and ex vivo protective activities of green and roasted coffee
The antioxidant properties of green and roasted coffee, in relation to species (Coffea arabica and Coffea robusta) and degree of roasting (light, medium, dark), were investigated. These properties were evaluated by determining the reducing substances (RS) of coffee and its antioxidant activity (AA) in vitro (model system beta-carotene-linoleic acid) and ex vivo as protective activity (PA) against rat liver cell microsome lipid peroxidation measured as TBA-reacting substances. RS of C. robustasamples were found to be significantly higher when compared to those of C. arabica samples (p < 0.001). AA for green coffee samples were slightly higher than for the corresponding roasted samples while PA was significantly lower in green coffee compared to that of all roasted samples (p < 0.001). Extraction with three different organic solvents (ethyl acetate, ethyl ether, and dichloromethane) showed that the most protective compounds are extracted from acidified dark roasted coffee solutions with ethyl acetate. The analysis of acidic extract by gel filtration chromatography (GFC) gave five fractions. Higher molecular mass fractions were found to possess antioxidant activity while the lower molecular mass fractions showed protective activity. The small amounts of these acidic, low molecular mass protective fractions isolated indicate that they contain very strong protective agents
Sindrome di Mayer- Rokitansky: Aspetti genetici, clinici, radiologici e prospettiveterapeutiche
La sindrome di Mayer-Rokitansky-Kuster-Hauser (MRKH) è una rara
anomalia congenita dell'apparato genitale femminile che consiste
nell'agenesia dell'utero e della vagina, ha una incidenza stimata di 1:4500, ed
in genere si presenta con carattere sporadico. Le ovaie e tube di fallopio
morfologicamente normali, cosi come lo sviluppo dei caratteri sessuali
secondari ed il cariotipo. Un’interazione di fattori genetici ed ambientali è
l’ipotesi eziopatogenetica più plausibile. La trasmissione sembra essere
autosomica dominante con penetranza incompleta ed espressivitĂ variabile.
Sono stati individuati diversi geni tra cui TCF2 e LHX1. La RMN è
particolarmente adatta per la sua multiplanarietà e l’attitudine allo studio dei
tessuti molli ed è più specifica ed accurata nella valutazione dell’aplasia
uterina rispetto all’ecografia. Il trattamento delle pazienti con sindrome MRKH
prevede la ricostruzione del canale vaginale che, in casi selezionati, si può
eseguire anche con metodiche non invasive “Franck's dilator method”,
tecnica Williams e Mc Indoe. Tra le prospettive terapeutiche anche il trapianto
di mucosa vaginale umana autologa “in vitro”, mediante vaginoplastica